Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (501-510 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 25, 2017
Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disordersEverard G B Vijverberg, Annemiek Dols, Welmoed A Krudop, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 20, 2020
Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age ContinuumNiccolo' Tesi, Sven J van der Lee, Marc Hulsman, et al.
Journal of Alzheimer'S Disease : JAD|February 28, 2012
Early onset Alzheimer's disease is associated with a distinct neuropsychological profileLieke L Smits, Yolande A L Pijnenburg, Esther L G E Koedam, et al.
Journal of Immunological Methods|July 7, 2009
Quantification of amyloid-beta 40 in cerebrospinal fluidNicolaas A Verwey, Robert Veerhuis, Harry A M Twaalfhoven, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's diseaseRoos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 28, 2010
Neuroanatomical and neuropsychological features of euthymic patients with bipolar disorderChristophe Delaloye, Fabienne de Bilbao, Guenaël Moy, et al.
Alzheimer'S Research & Therapy|August 23, 2023
Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genesFran C van Heusden, Anne M van Nifterick, Bryan C Souza, et al.
Frontiers in Genetics|January 7, 2022
The Effect of Alzheimer's Disease-Associated Genetic Variants on LongevityNiccolò Tesi, Marc Hulsman, Sven J van der Lee, et al.
Frontiers in Psychiatry|June 20, 2022
Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-RestrictionsLisa Waterink, Els D Bakker, Leonie N C Visser, et al.
Dementia and Geriatric Cognitive Disorders|June 15, 2007
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS StudyRaija Ylikoski, Hanna Jokinen, Pia Andersen, et al.
Pageof 91

Showing results (501-510 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 25, 2017
Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disordersEverard G B Vijverberg, Annemiek Dols, Welmoed A Krudop, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 20, 2020
Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age ContinuumNiccolo' Tesi, Sven J van der Lee, Marc Hulsman, et al.
Journal of Alzheimer'S Disease : JAD|February 28, 2012
Early onset Alzheimer's disease is associated with a distinct neuropsychological profileLieke L Smits, Yolande A L Pijnenburg, Esther L G E Koedam, et al.
Journal of Immunological Methods|July 7, 2009
Quantification of amyloid-beta 40 in cerebrospinal fluidNicolaas A Verwey, Robert Veerhuis, Harry A M Twaalfhoven, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's diseaseRoos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 28, 2010
Neuroanatomical and neuropsychological features of euthymic patients with bipolar disorderChristophe Delaloye, Fabienne de Bilbao, Guenaël Moy, et al.
Alzheimer'S Research & Therapy|August 23, 2023
Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genesFran C van Heusden, Anne M van Nifterick, Bryan C Souza, et al.
Frontiers in Genetics|January 7, 2022
The Effect of Alzheimer's Disease-Associated Genetic Variants on LongevityNiccolò Tesi, Marc Hulsman, Sven J van der Lee, et al.
Frontiers in Psychiatry|June 20, 2022
Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-RestrictionsLisa Waterink, Els D Bakker, Leonie N C Visser, et al.
Dementia and Geriatric Cognitive Disorders|June 15, 2007
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS StudyRaija Ylikoski, Hanna Jokinen, Pia Andersen, et al.
Pageof 91